• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Minerva Surgical names Kaile Zagger chief commercial officer

Minerva Surgical names Kaile Zagger chief commercial officer

March 23, 2023 By Sean Whooley

Kaile Zagger headshot Minerva Surgical
Kaile Zagger, new CCO at Minerva Surgical

Women’s health company Minerva Surgical (Nasdaq:UTRS) announced that it appointed Kaile Zagger as its new chief commercial officer.

Zagger’s role includes helping to guide the strategic growth of the company as it advances in the women’s healthcare space.

“We are excited to have Kaile as our new Chief Commercial Officer for her proven track record of driving exponential growth and productivity while delivering bottom-line results,” said Todd Usen, president and CEO of Minerva Surgical.

Usen, the former Activ Surgical CEO, took over the corner office at Minerva at the beginning of the year. The company develops abnormal uterine bleeding (AUB) treatments. It closed a private placement worth $30 million last month.

“Beyond her professional acumen, Ms. Zagger’s passion for channeling her leadership experience into companies that improve the quality of healthcare for women and children aligns with our mission at Minerva Surgical, and we are pleased to welcome her to the team,” Usen added.

About new Minerva Surgical CCO Kaile Zagger

Zagger’s experience includes more than 20 years in the healthcare industry. Her roles span sales, organizational development, growth acceleration, restructuring and operational excellence.

She held positions of increasing responsibility at companies including Boston Scientific, Intuitive Surgical, GE HealthCare, Philips and Change HealthCare. Zagger also held C-suite positions for private and public companies while leading multiple large-scale transformations, Minerva said.

Additionally, Zagger has served as a board member for private organizations and nonprofits. She co-founded a non-profit foundation seeking to eradicate late-stage female reproductive cancers.

“Women’s health is a uniquely personal field of healthcare that I am committed to transforming,” Zagger said. “It is an important time in women’s health, and we have much work to do to progress this area of care. I am excited about the future and thrilled to work alongside this management team to re-position the organization as a leader in this important segment.”

Filed Under: Business/Financial News, Gynecological, Women's Health Tagged With: Minerva Surgical Inc., Personnel Moves

More recent news

  • Retired Stryker leader Tim Scannell dies at 62
  • HighLife raises more than $90M to advance its TMVR system
  • UltraSight raises $24M in Series B2 to scale AI-guided cardiac ultrasound technology
  • Convatec launches new hydrophilic option for self-catheterization
  • Novo taps Nanexa for long-acting obesity injectables with €1.17B pact

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy